163
Views
15
CrossRef citations to date
0
Altmetric
Case Series

A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia – Case Reports

ORCID Icon, , , ORCID Icon, ORCID Icon, , , , & show all
Pages 1039-1046 | Published online: 29 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Suzana Erico Tanni, Alexandre Todorovic Fabro, André de Albuquerque, Eloara Vieira Machado Ferreira, Carlos Gustavo Yuji Verrastro, Márcio Valente Yamada Sawamura, Sergio Marrone Ribeiro & Bruno Guedes Baldi. (2021) Pulmonary fibrosis secondary to COVID-19: a narrative review. Expert Review of Respiratory Medicine 15:6, pages 791-803.
Read now

Articles from other publishers (14)

Irina Le-Deygen, Anastasia Safronova, Polina Mamaeva, Yana Khristidis, Ilya Kolmogorov, Anna Skuredina, Peter Timashev & Elena Kudryashova. (2023) Liposomal Forms of Fluoroquinolones and Antifibrotics Decorated with Mannosylated Chitosan for Inhalation Drug Delivery. Pharmaceutics 15:4, pages 1101.
Crossref
Somayeh Bazdar, Anastasia K. A. L. Kwee, Laura Houweling, Yolanda de Wit-van Wijck, Firdaus A. A. Mohamed Hoesein, George S. Downward, Esther J. Nossent & Anke H. Maitland-van der Zee. (2023) A Systematic Review of Chest Imaging Findings in Long COVID Patients. Journal of Personalized Medicine 13:2, pages 282.
Crossref
Renata Streck Fernandes, Matheus Rodrigues Teixeira Netto, Fabiano Barbosa Carvalho & Katya Rigatto. (2022) Alamandine: A promising treatment for fibrosis. Peptides 157, pages 170848.
Crossref
Han Zhong, Yang Zhou, Shu-Ya Mei, Ri Tang, Jin-Hua Feng, Zheng-Yu He, Qiao-Yi Xu & Shun-Peng Xing. (2022) Scars of COVID-19: A bibliometric analysis of post-COVID-19 fibrosis. Frontiers in Public Health 10.
Crossref
Laura Bergantini, Alessandro Mainardi, Miriana d’Alessandro, Paolo Cameli, David Bennett, Elena Bargagli & Piersante Sestini. (2022) Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review. Frontiers in Pharmacology 13.
Crossref
Essam Eldin A. Osman, Alnawaz Rehemtulla & Nouri Neamati. (2021) Why All the Fury over Furin?. Journal of Medicinal Chemistry 65:4, pages 2747-2784.
Crossref
Irina M. Le-Deygen, Anastasia S. Safronova, Polina V. Mamaeva, Anna A. Skuredina & Elena V. Kudryashova. (2022) Cholesterol Significantly Affects the Interactions between Pirfenidone and DPPC Liposomes: Spectroscopic Studies. Biophysica 2:1, pages 79-88.
Crossref
S Farooq, S Han, S A -D Mohammad & H Ammar. (2021) Post-COVID-19 pulmonary fibrosis. QJM: An International Journal of Medicine 114:9, pages 655-656.
Crossref
Alex Pozdnyakov, Andrew Jin & Mazen Bader. (2021) Reactivation of Pulmonary Tuberculosis in a Patient With COVID-19. Infectious Diseases in Clinical Practice 29:6, pages e468-e470.
Crossref
Ahmed Miqdhaadh, Hisham Ahmed Imad, Aminath Fazeena, Thundon Ngamprasertchai, Wang Nguitragool, Emi E. Nakayama & Tatsuo Shioda. (2021) Multisystem Inflammatory Syndrome Associated with SARS-CoV-2 Infection in an Adult: A Case Report from the Maldives. Tropical Medicine and Infectious Disease 6:4, pages 187.
Crossref
Michael Kalafatis. (2021) COVID-19: A Serious Vascular Disease with Primary Symptoms of a Respiratory Ailment. The Journal of Applied Laboratory Medicine 6:5, pages 1099-1104.
Crossref
Rebecca C. Robey, Katie Kemp, Philip Hayton, Dalia Mudawi, Ran Wang, Melanie Greaves, Veronica Yioe, Pilar Rivera-Ortega, Cristina Avram & Nazia Chaudhuri. (2021) Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service. Advances in Therapy 38:8, pages 4505-4519.
Crossref
Shiva Rattan Ambardar, Stephanie L. Hightower, Nikhil A. Huprikar, Kevin K. Chung, Anju Singhal & Jacob F. Collen. (2021) Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic. Journal of Clinical Medicine 10:11, pages 2452.
Crossref
Alessandro de SIRE, Elisa ANDRENELLI, Francesco NEGRINI, Michele PATRINI, Stefano G. LAZZARINI & Maria G. CERAVOLO. (2021) Rehabilitation and COVID-19: a rapid living systematic review by Cochrane Rehabilitation Field updated as of December 31st, 2020 and synthesis of the scientific literature of 2020. European Journal of Physical and Rehabilitation Medicine 57:2.
Crossref